Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Visiopharm logo — Visiopharm® is a world leader in AI-driven digital precision...

Visiopharm

Visiopharm® is a world leader in AI-driven digital precision pathology software.

Founded 2001 Denmark Denmark 96 employees Venture round Total: $95.00M Health Care

General Information

Company Name Visiopharm
Founded Year 2001
Location Denmark Denmark
Founders / Decision Makers
Team member
Employees 96
Industries Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Visiopharm. To contact Visiopharm, visit visiopharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Visiopharm compare?

A PDF of Visiopharm and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Visiopharm soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Visiopharm

Visiopharm is a world leader in AI-driven digital precision pathology software. The company, founded in 2002, offers AI-driven precision pathology software for research and diagnostics. In the research sector, Visiopharm provides tools for scientists, pathologists, and image analysis experts to produce accurate data for various tissue-based research. In the diagnostics arena, the company is a leader in clinical applications, with eight diagnostic algorithms cleared under IVDR for EU customers. These applications provide diagnostic decision support and can be easily integrated into existing lab workflows. Based in Denmark, Visiopharm operates internationally with over 750 customer accounts in more than 40 countries. The company has headquarters in Denmark’s Medicon Valley, with offices in Sweden, the UK, Germany, the Netherlands, and the United States. Additionally, it has local representation in France and China. Their last investment, a Venture Round investment at 01 September 2020, saw participation from Northcap, BankInvest Group, Vaekstfonden, ATP, and C.L. Davids Fond. As a leading player in the Health Care industry, Visiopharm continues to expand its presence and offerings in the global market.

Business keywords: AI-driven software, precision pathology, research tools, diagnostic algorithms, IVDR clearance, international operations, customer accounts, Medicon Valley, global presence

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 5
Northcap Vaekstfonden ATP
Northcap, Vaekstfonden +3
01 Sep 2020
Venture Round kr95.00M 2
Northcap ATP
Northcap, ATP
23 Aug 2018
Venture Round Undisclosed 1
Northcap
Northcap
05 Oct 2007

Latest News

View All
Focused Energy raises $240M, TrueLayer acquires In3, and London regains top spot — Tech
Focused Energy raises $240M, TrueLayer acquires In3, and London regains top spot
Tech May 29, 2026
Finland’s Grundium acquires Denmark’s Visiopharm to build an end-to-end AI precision pathology platf... — Eu-startups
Finland’s Grundium acquires Denmark’s Visiopharm to build an end-to-end AI precision pathology platform
Eu-startups May 25, 2026

Visiopharm Alternatives & Competitors

Visiopharm vs
Aperio
Aperio United States

For over a decade, Aperio has advanced the technology that enables glass slides to be digitized and...

Debt Financing
86 employees
Biotechnology, Health Care
Visiopharm vs
Maxwell Plus
Maxwell Plus

Empowering clinicians, researchers, and companies with advanced AI tools for swift and accurate clin...

Non Equity Assistance
AI, Health Care
Visiopharm vs
StatLab
StatLab United States

Providing you easy access to high-quality products for histology, advanced diagnostics and cytology—...

193 employees
Health Care, Manufacturing

FAQ About Visiopharm

Visiopharm® is a world leader in AI-driven digital precision pathology software.
Visiopharm was founded in 2001.
Visiopharm is headquartered in Denmark.
Visiopharm operates in Health Care. Its work centres on AI-driven software, precision pathology, research tools and diagnostic algorithms.
Visiopharm has approximately 96 employees.
Visiopharm has completed 3 funding rounds, raising a total of $95.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Visiopharm include Aperio, Maxwell Plus, StatLab , Applied Spectral Imaging (ASI), DataTecnica LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Visiopharm and Aperio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Visiopharm, https://bouncewatch.com/company/visiopharm, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes